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CHAPTER - I 
INTRODUCTION 
The population of the aged was recorded as 32 
million in the 1951 census, has increased to 58.68 million 
in 1991 and is projected to increase further to 75.70 
million by 2 001. The decadel growth of 10.74 million 
between 1981 and that of 11.5 million between 1981 and 
1991 census in highly significant both in terms of number 
and rate of growth. The projected decadel growth for 
1990s of 21.81 million and rate of growth of 38.42 percent 
will further increase the population of the aged 
(Swaminadhan, 1996) . The increase in the percent of the 
elderly is occuring because of higher life expectancies 
arising from improved nutrition and better medical care. 
Chronic diabling condition become more common with age. 
The over 75 age group is especially vulnerable to mental 
disorders. Thus it is a challenge in the years ahead for 
clinical psychologists to meet the needs of these older 
adults through the application of individual controlled 
techniques. 
PERSPECTIVES ON DRUGS AND AGING : 
The elderly are heavy consumers of drugs. A large 
majority of elderly patients intake drugs on a regular 
basis, but not always under close supervision by their 
doctors. On an average many elderly patients take 3-5 
drugs daily and some take more than this. Although the 
risk of adverse effects is well known to increase in old 
age, being 2 to 3 times consumer after the age of 60 
years than before this age. The incidence also increases 
with the number of drugs ta.ken, rising sharply in patients 
who are using more drugs daily. 
Old age is characterised by many changes; familial, 
socioeconomic, emotional, sociocultural and physiologic 
and environmental factors: Each of these factors influences 
drug therapy in the elderly patient. As people become 
aged, they are more likely to encounters a variety of 
medical and emotional problems, and to be exposed to more 
medicdiion. Surveys have found that 65-90% of elderly 
patients being treated for psychiatric conditions also 
have atleast one physical disorder (Prien, 1980). It is 
not surprising that many elderly patients are taking 
multiple prescribed medications on a regular basis. As a 
new condition arises the patient may be given an 
additional prescription that will interact v/ith an under 
line medical problem or with previously prescribed medi-
cation. The elderly may also be consuming abusive drugs 
like alcohol, tobacco or coffeine which may interact with 
prescribed medication. Although no age group is immune to 
adverse drug reactions, studies have found that patients 
over age 70 have approximately twice as many drug 
reactions as do people under age 50 (Seidl et al., 1966). 
The physician must recognised the symptoms of 
psychiatric illness in the elderly patient who is 
suffering from a disorder of cognition, mood, or mentation. 
The clinician must not hastely attribute changes in mental 
function to senility just because the patient is 80 years 
of age (Bernstein 1983; Thai, 1982). Drug therapy in the 
elderly may be complicated and subject to adverse 
reactions. 
The misuse of prescribed legal drugs is a serious 
problem in the aged population than abuse of illicit drugs. 
The prescription of psycho-active substances even in 
normal doses can have adverse side-effects in a wide range 
of disorders among the elderly. Three reasons seems to be 
important for the misuse of prescribed psychotropic 
substances. 
First, some people use medication in order to alleviate 
psychological disorders such as anxiety, depression, 
insomnia , hypochondriasis, essential hypertension etc. 
Second, others may take prescribed drugs to abuse and 
dependence. Abuse of legal drugs can be deliberate or 
inadvertant. Dependence on medication can develop. 
particularly in anxious, depressed and hypochondriachal, 
older adults (LARue, Dessonville, & Jarvik, 1985). 
Third/ some may not take drugs as per pre-sufferer, 
perhaps though misdiagnosis, ignorance, or lack of 
finances. 
The prevalence of geropsychiatric disorders in our 
country has been taken up by various researchers and 
varied results were found: Racket al., 1952 - 89/1000 
population, Dube, 1970 - 23.3/1000 population^ Mandi, et 
al., 1975 - 33.3/1000. A study conducted by the 
department of psychiatry K.G. Medical College, Lucknow 
found a prevalence rate of 213/1000 population in persons 
aged 55 and over, and 437/1000 in those aged 75 and over, 
the various disorders ranged from depression (68.7%) to 
senile dementia (18.7%). The psychosocial factors play an 
important role in predisposition towards geriatric 
disorders, some of the common ones are retirement from 
work, demise of spouse, reduced income, changing attitude 
of the younger generation and new demands for adjustments^ ^ 
(Ramachandran et al., 1981; Rao and Madhavan, 1982; Sethi, 
1982). 
Until recently the effectiveness of drug therapy 
in the alleviation of psychological disorders of old-age 
was not given due attention by mental health professionals, 
mainly by psychologists. As the number (60 million) of 
people living beyond the age of 60 continues to grow, it 
is imperative to study the psychological disorders from 
which some older people suffers and to suggest ways of 
preventing and alleviating the suffering of this section 
of our society. 
The present study is directed towards identifying 
the psychophysical consequences associated with the drug 
dependent elderly individuals to understand why they are 
taking a drug/drugs and how they feel after taking a 
drug/drugs. 
PSYCHOTROPIC DRUGS; 
The psychotropics are the main category of mood-
altering drugs prescribed by doctors. They include 
hypnotics,sedatives, psychostimulants, anxiolytics psycho-
dysleptics or Hallucinogens, antihypertensive drugs and 
antidepressants medication. V7idespread and heavy use of 
psychotropic drugs amongst the elderly has been confirmed 
world wide. The reason for the use of psychotroic drugs 
is the multiplicity. Nature of anxiety and bodily 
symptoms that stand from chronic degenerative diseases. 
The use of sedatives and minor tranquilizers has risen by 
2 to 3 times in the last three decades among the older 
people. For older people these and other drugs inevitably 
produce mental impairment. 
ANTIDEPRESSANTS : 
It has been estimated that one-third to one-half of 
all depressive illnesses occur in lat^r life. Treatment 
for the short-term is good, but over the long-term depre-
ssion can show high morbidity and a tendency to recur 
(Jacoby, 1981; Murphy, 1983). 
Sedatives and Tranquilizers are the most frequently 
used drug Such drugs only have a transient calming effect, 
with low resolution of the morbid depression; increasing 
dosage, polypharmacy, or long-term drug dependency may 
follow. In the true biological depressive illness (some 
times called psychotic or endogeneous depression) an 
appropriate dosage schedule of antidepressant drug can 
lead to a remission; however, these drugs carry risk v/hich 
are increased in the elderly because of altered drug 
handling and an enhanced sensitivity when drug elimination 
is delayed the adverse effects are much more frequent and 
profound (Neis et al., 1977). 
It may be noted that true antidepressant drugs are 
not stimulants or (euphoriants, having an immediate action 
on the individual. Their antidepressant effect does not 
appear for 2 to 3 weeks. Newer antidepressants drugs are 
of low special value in treating the elderly or others 
with intolerable social situation or unresolved problems 
associated with bereavement. The prescription of 
sedatives-plus an antidepressants, and neuroleptics 
associated with antidepressants enhances the side effects. 
Moreover they do not have an antidepressant action. 
Sleeplessness/ anxiety and agitation, common features of 
a depressive illness, can all be controlled by a single 
true antidepressants with a sedative effect(e.g.)dothiepin 
or Mianserin, given mainly at night. 
There are more than 40 antidepressant drugs on the 
market. Convincing evidence that one antidepressant is 
superior to other perhaps is not available. iMany are 
combination drugs where the dose of the antidepressant is 
not of adequate potency to reverse a depressive illness. 
The first antidepressant drug to have a major impact was 
iraipramine (tofranil) introduced in the late 1950s. No 
other antidepressant drugs have been found to have 
consistant advantage in efficacy over imipramine (Imlah, 
1981) or in speed of action, some drugs have fewer side 
effects and may be better tolerated by older people. 
Newer and more expensive antidepressants such as 
trazodome and Mianserin, have been particularly recommended 
for older people. These drugs have side effects. Lithium 
salts are now used in selected patients with intractable 
depression. However, in the case of lithium there is a 
very narrow line in terms of its therapeutic and toxic 
dose. 
Tricyclic Antidepressants can be lethal in over 
dosage. More recently there has been a steep rise in over 
dosage with antidepressant drugs, reflecting a massive 
increase in their prescription. Anxiety is now being 
expressed that drug specifically for depressive illnesses 
are being used indiscriminately (Tyrer, 1978; Prescott and 
Highley, 1985). 
Amongst the tricyclic drugs, desipramine and 
trazodole causes fev^ ers side effects, but trazodole cause 
much sedation. 
Tetracyclic antidepressants are valuable for the 
elderly. Some tetracyclic antidepressants (e.g., Mapratiline 
is said to v;ork more quickly than others, and some (desi-
miprantine, maprotlline. Mianserin) are to be less likely 
to cause anticholinergic side effects. Mianserin is also 
said to be less likely to cause cardiovascular side 
effects. 
There are two forms of Manoamine Oxidase Inhibitors: 
(MAOIs). M.A.O-A and M.A.O-B, which are used for the 
management of depression. M.A.O-A binds preferentially to 
Noradrenaline, adrenaline, Benzylamine and Phemylalanine.The 
newer M.A.O-A include clorgyline and Moclobemide. Drugs 
with which M.A.O inhibitors can interact adversely include 
Ephedrinine, Methylphenidate, Phenylephrine and others 
sympathorairaetic medications. Adverse reactions including 
a hypertension may also result if the M.A.O. inhibitors 
are used in conjuction with the tricyclic antidepressants 
(Spiker and Pughi 1976). The M.A.O. Inhibitors have been 
proposed as a treatment of "a typical depression", with 
concomittant symptoms of a hysteric disorders or somatiza-
tion disorders (Quitkin, Rifkin and Klein, 1979). The 
M.A.O. Inhibitors can also cause hypotension by sympathe-
tic ganglion block. 
DIHYDROERGOT ALKALOIDS; 
A preparation containing three dihydrogenated ergot 
alkaloids (hydergine), given in a dose of upto 3 mg per 
day, has been used extensively for the treatment of 
organic mental disorders. Although the neurophysiologic 
evidence that this preparation significantly improves 
cognitive functioning or the utilization of oxygen by 
neurons continues to be debated in the literature, their 
efficacy in clinical trials has generally been established 
(Yesavage, et al., 1979). According to Cole (1980) this 
drug may serve as a mild antidepressant. There is also 
evidence that the drug stablizes the cyclic AMP system and 
has mild dopaminergic actions. Cole (1980) found that 
significant drug versus placebo differences could be 
demonstrating in four symptoms areas: physical symptoms; 
activities of daily living; memory disorientation and 
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confusion and depression. Studies show greater impairment 
in depressive symptom, than in any other area. This drug 
is also found beneficial in the treatment of mild 
depressive symptoms in older persons. Blazer and Mosby 
(1982) found the drug to be useful for moderately healthy 
older patients with a mixed clinical picture of 
depression and cognitive impairment but not moderate to 
severe depression. 
Lithium is excreated by aging kidneys, in order 
to achieve and maintain therapeutic serum level. Close 
monitoring of serum lithium levels is essential, but 
symptoms of lithium toxicity have been reported in elderly 
patients with serum lithium levels with in the accepted 
therapeutic range. Lithium is also used in the treatment 
of mania. The mode of action of lithium is uncertain; it 
modifies receptor responses to neurotransmitter 
monoamines via cyclic A.M.P., and an effect on cyclic 
A.M.P. may also account for its capacity to effect 
adversely both thyroid and kidney function. Likewise 
electrocardiographic changes may occur during lithium 
treatment in the absence of lithium intoxication. 
Some persons may experience increased thirst, 
polydypsia, polyurea, hand tremor, nausea and diarrhoea 
early in the course of lithium treatment or in the 
presence of excessive serum lithium concentration. These 
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symptoms generally appear as lithium therapy is continued 
or in some cases in response to a reduction in lithium 
dose. Although some elderly patients with recurrent 
depressive disorders will require indefinite maintenance 
with antidepressant drugs many such individuals will 
achieve satisfactory prophylaxis against recurrent 
depression by the administration of lithium carbonate. 
As the plasma concentration rises, central nervous 
system effects become more prominent (coarse tremor), 
drowsiness/ giddiness, ataxia, tinnitus, blurred vision, 
dysarthria, muscle twitcMng and Oedema can occur. In severe 
over dose the patient may be unconscious and develop 
cardiac dysrhythmias, hypotension and renal failure. 
Viloxazine did not produce anticholinergic side 
effects in trials in the elderly, but nausea, vomitting, 
loss of weight and a transient early rise in blood 
pressure have been reported. A rebound of depression may 
follow its withdrawal. If given to patients on Phenytoin, 
the dosage of the latter may need to be reduced. 
Nomifensine is also less likely to produce anti-
cholinergic side effects or cardiovascular problems, it has 
been well tolerated in trials in elderly patients. 
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ANTIHYPERTENSIVE DRUGS : 
Antihypertensive drugs are regularly prescribed for 
older people. Side effects from drugs used to treat 
hypertension in older people (including diuretics) are 
particularly common. Excessive falls of blood pressure 
(hypotension) and of blood salts (especially Potassium and 
Sodium^/ as well as dehydratior. from excessive fluid loss/ 
can lead to inconsistence, weakness, immobility, confusion 
and bad sores. These side effects occur most frequently in 
older patients and may cause considerable distress. 
Attacks of dizziness and fainting due to sudden fall of 
blood pressure on steading are a frequent consequence of 
the drug treatment. 
All antihypertensive drugs can cause postural hypo-
tension in elderly patients. In the elderly, the postural 
hypotension, causing giddiness, faintness and confusional 
states (Wollner^ et al.,. 1979). Over medication with hyper-
tensive drugs is a major cause for fatal strokes. It is 
generaly recognised that the more powerful antihyper-
tensive drugs such as the adi anergic, neuronblockers 
(e.g. Gunethidine) and Vasodelators (e.g. Hoidrallazine) 
are obvious causes of hypotension episodes. Diuretics* 
betablockers, raethyldopa, vasodialators/ digital prepara-
tions are some of the major drugs used for treating hyper-
tension. Amongst the top five drugs prescribed alteast 
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four are used in hypotensive treatment (Melville & 
Johnson, 1982). Reserpine presents a special hazards in 
that it .may precipitate depression quite conunonly in old 
people. 
ANXIOLYTICS; 
Drugs that reduce anxiety are referred to as 
sedatives, tranquilizers or anxiolytics.Barbiturates were used 
for the fnxiety disorders, but because of undesirable side 
effects and their addictive properties OJ. a low 
therapeutic index, they were supplemented in the 1950s by 
two other classes of drugs - Propanediols (e.g., Miltown) 
and benzodiazepines (e.g., Valium & Ativcin). The latter 
are widely used today and are of demonstrated benefit; 
however, while the risk of lethal overdose is not as great 
with barbiturates, they are addicting and produce a severe 
withdrawal syndrome (Schweizer et al., 1990). 
The benzodiazepines are the most frequently used 
drugs in the treatment of anxiety symptoms in the elderly. 
Leonard (1994) posits that the use of drugs require an 
understanding of the Pharmacokinetic and pharmacodynamic 
characteristics that are often altered in aged patients. 
Thus the rate of absorption of the drugs, and its volume 
of distribution, are the major determinants of the onset 
of pharmacological action and the duration of the 
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therapeutic effects. The volume of the distribution is 
the term used to relate the quantity of drug in the body 
relative to its concentration in the blood or plasma. The 
volume of distribution of any drug varies widely even with 
in a population of patients of similar age and • the same 
sex. The volumes of distribution of a drug can change as a 
function of the patient's age, gender, physical status and 
body composition. Drug clearance is expressed as the rate 
elimination of the drugs by all routine e.g., urine, 
sweat, expired air, feaces as a function of the concentra-
tion of the drug in the blood or other tissues. The term 
"elimination half life" is used as an index of the rate at 
which the drug is removed from the body. Once it has 
reached its steady state concentration in the blood. In 
general, the older the patient the longer the th value. 
This is important as such drugs as the benzodiazepines and 
others sedatives may accumulate and lead to adverse side 
effects. 
(1) Ultra Short Benzodiazepines; 
This type of benzodiazepines have th values of less 
than 5 hours and do not accumulate, drugs in the class 
include midazolam, triazolam, brotizolam, which are used 
predominantly as hypnotics in the elderly. 
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(2) Short and Intermediate Half-life Benzodiazepines; 
This class of drugs have elimination half-lives of 
of 5-24 hours. This type of drugs include lorazepam, 
alprazolam/ temazepam and oxazepam. The short and 
intermediate half-life benzodiazepines are usually .used 
as anxiolytic agents in the elderly patients. The drugs of 
this types, do not usually accumulate to any extent and 
accumulation of their active metabolites is not 
significant even in the elderly. 
(3) Lonq-half-life Benzodiazepines; 
This type of benzodiazepines have elimination t^s 
values greater than 24 hours and include such drugs as 
nitrazepam/ flurazepam/ and flunitrazepam. Such compounds 
frequently have active metabolites which accumulate during 
chronic administration. The elimination t^ j values of these 
drugs are frequently increased/ relative to healthy young 
controls/ due to reduction in renal clearance which occurs 
in all elderly patients. 
Most psychotropic drugs are highly lipophillic and 
the increased fat to lean body mass ratio in the elderly 
patients/ and decrease metabolism and excretion means 
that the half-lives of most psychotropic drugs are 
increased. The benzodiazepines/ anxiolytics and hypnotics 
are low exception. Following a single dose of 
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Chlordiazepoxide/ diazepam, or flurazepaia; the time for 
elimination of the parent compounds and their active 
metabolites can be as long as 72 hours. For this reason it 
is now accepted practice to administer a short acting 
benzodiazepines, e.g. brotizolam, oxazepam/ triazolam, 
medazolam or temazepam only as needed and for as short a 
period as possible. The side effects and dependence is 
potential of the anxiolytic and sedative-hypnotics are 
well known and can usually be curtailed by slowly reducing 
the dose of the drugs over a period of 1-2 weeks. 
Other drugs used as anxiolytics include the 
B-adrenoceptor antagonist such as Propranolol, these 
drugs are chiefly effective against symptoms mediated via 
physiological mechanisms utilizing B-adrenergic pathways. 
The neuroleptic agents have also been used in the manage-
ment of anxiety. The elderly with organic brain damage and 
behavioural problems tolerate the benzodiazepines badly. 
Several tricyclic antidepressives such as amitriptyline, 
doxepin, dothiepin and Mianserin have pronounced sedatives 
effects and are the treatment of the first choice in 
patients with depression and anxiety. Drug treatment 
reduces the choice of benzodiazepines and adjustment of 
its dosage among the majority of anxious patients. 
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NEUROLEPTICS : 
Neuroleptics are given to older people for their 
specifically antipsychotic effects in Schizophrenia and in 
psychotic states of extreme excitement and Elation (Rosen^  
et al / 1990). They are also used for their non-specific 
effects upon disturbed behaviour. 
Neuroleptics can also have the paradoxical effects 
of increasing anxiety and aggression (Rice & Arie, 1981). 
Their use - especially long-term - have the risk of a wide 
range of adverse side effects. Neuroleptics seriously 
impair movements, producing stiffness and tremor as in 
Parkinson's disease, as well as restless 'Jitters' and 
involuntary movements, distorting the face, mouth and 
tongue. Barnes (1984) found that all these effects are 
produced significantly more amongst older people, who may 
already have movement problems. 
Many drugs, including antiparkinsonian agents, 
guinidine, antihistamines, and psychotropics can induce an 
anticholinergic type psychosis or delirium. The 
administration of physostignim, a cholinesterase inhibitor 
may rapidly reverse and anticholinergic behavioural 
disturbance. Agitated elderly people who have 
anticholinergic psychosis may require cautious use of 
Haloperidol (0.25 to 1 mg) or amobarbital in small doses 
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of 30 to 100 mq, orally or intramuscularly. The use of low 
potency antipsychotic agents with greater anticholinergic 
action, such as Chlorpromazine and thioridazine is to be 
avoided in patients presenting evidence of anticholinergic 
deliria. 
Age is the major variable influencing both preva-
lence and severity of Tardive dyskinesia (Barnes et al, 
1983; Kane & Smith, 1982). Sweet et al, (1992) have 
reported a rate of 21% for Tardive dyskinesia in patients 
with exposure to neuroleptics. The older the patient when 
starting neuroleptic drug treatment the more rapidly the 
condition develops. The use of antiparkinsonian agents in 
the elderly to counteract the effect of the neuroleptic 
can produce confusion, restlessness, hallucination, out 
bursts of delirious shouting and impaired memory (Drug and 
Theurapeutic Bulletin, 1984). 
There are many other important side effects amongst 
the neuroleptic drugs including loss of temperature 
control, sudden falls of blood pressure (leading to faints 
and falls), skin reactions jaundice, dirug interactions, 
weight gain and difficulties in sexual functioning (Kotin, 
et al, 1976). Trivedi and Srivastava, (1994) have reported 
some other side effects of neuroleptics that include 
Hepatotoxicity, ratinopathy, agranulocytosis, skin 
reactions and sudden death. 
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Gilleard, et al, (1983) drive a profile of the 
characteristic of the elderly institutiohalized patients 
to whom neuroleptics are likely to be administered -
namely some one confused/ partially in t(i)uch with his or 
her sarrounding, weepy, never cheerful, disturbing to 
I 
others at night and on current doses of hypnotics. 
Simple observations or subjective p^ erception on the 
use of major tranquilizers revealed that finer levels of 
consciousness and alertness are seriously blunted, 
specially as the dosage arises. Dosages of thioridazine 
(melleril). A safer neuroleptic for the elderly, of 25 mg 
three times a day is, in any one over 75, almost certain 
to produce marked inertia and drowsiness after long-term 
usage. Neuroleptics can cause many other problems such as 
severe falls of blood pressure, drowsiness, confusion and 
parkinsonism. 
Another over prescribed drugs is prochlorperazine 
(Stemetil). This is a drug prescribed fop the ubiquitous 
symptoms of giddiness in the elderly. Giddiness may stem 
from sudden falls of blood pressure which prochlorperazine 
itself readily induces - especially with 61der peole. Drug 
induced parkinsonisms is much common than most people have 
been led to believe (Williamson, 1984). 
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Anticholinergic agents* such as thioridazine and 
chlorpromazine worsen the behaviouiral disturbance 
(Bernstein, 1983). High potency antipsychotic drugs are 
the agents of choice in managing agitation and psychotic 
manifestation in patients with nondrug-induced organic 
psychosis. Antipsychotic drugs have curative value in the 
treatment of Alzheimer's Disease, yet the^ often allow the 
patients to be more comfortable and increase the comfort 
of those who live with the individuals. 
Neuroleptic drugs that benefits Schizophrenia, 
e.g., Phenothiazines, butyrophenones, thioxanthenes, are 
competitive antagonists of dopamine (dopamine-D- receptor 
blockers) and a precursor of dofiamine, Levadopa 
predictably exacerbates symptoms of Schizophrenia. D. 
receptors, postsynaptic and presynaptic (autoreceptors) 
are also involved. 
Neuroleptics are the most effective drugs and can 
greatly reduce positive symptoms, e.g., aggression, 
hyperactivity, delusions and hallucinations. But negative 
symptoms, e.g., apathy respond less well. 
HYPNOTICS : 
Most of the elderly people havq the problem of 
sleeplessness, many of them regularly rteceive hypnotics. 
Many elderly people who sleep in the day time complaint of 
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night time insomnia, instead of day time hypersomnia. 
Older persons frequently do not maintain a strict schedule 
of sleeping at night and staying awake during the day 
time. The elderly are less tolerant of hypnotics. The old, 
particularly those with organic brain failure, may become 
confused with hypnotics and an occasional patients become 
excited or has nightmares on a part;icular drugs; a 
neuroleptic (promazine) may be used alone, or even 
cautiously with a hypnotic. Confusion is more likely if a 
patient who has taken a full dose of hypnotic is kept away 
by pain; adequate analgesia should accompany the 
hypnotic. 
Hypnotic medication can be dangerous drugs for 
several reasons such as respiratory depression, apnea, 
abuse, withdrawal reactions, performance deficits, 
allergy, hypersensitivity, distortion of normal sleep 
patterns etc. As the Greeks say "Sleep is the younger 
sister of death". If sleep is produced, it is producing a 
little bit of death in a number of ways. Several classes 
of medication are commonly prescribed as, hypnotics, 
barbiturates, non benzodiazepine, (non B^non B ). 
s 
Barbiturates hypnotics have been in popular use for 
about 75 years. This means that many of the properties of 
barbiturates are well recognized. These include toxicity 
22 
with overdose (10 to 20 dose units produces severe 
toxicity or death), stimulation of liver enzymes (which 
leads to more rapid metabolism not only of the barbitu-
rates but other drugs# such as oral anticoagulants and 
antidepressants), and liability to physical dependence 
when taken in large amounts (over 600 mg/day). Withdrawal 
insomnia has been reported when some hypnotics, including 
barbiturates are discontinued, atleast when higher doses 
have been administered for many days. Among the virtues of 
the barbiturates hypnotics are : (1) absence of 
progressive accumulation of the parent compound or its 
metabolites with nightly administration, and (2) the 
absence of an association between renal impairment and 
adverse effects; such a relationship was found for 
flurazepam, nitrazepam and chloral hydrate (Jick, 1977). 
Benzodiazepines hypnotics are relatively safe and 
effective (Power^et al., 1985). Castledan,et al., (1977), 
have demonstrated an increased sensitivity to nitrazepam 
(Mogadon) in old age. Swift et al., (1980) observed much 
altered pattern of drug handling of diazepam (Valium) in 
old age. Unsteadiness/dizziness and nausea are the 
particular side effects of sleeplessness in the day. 
The postural hypotension, i.e., sudden falls in 
blood pressure on standing was not uncommon in the elderly 
on nitrazepam. Nitrazepam has been shown again and again 
to cause impairment of mental functions, specially in the 
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elderly (Oswald; 1984a). The effect of chronic use of 
hypnotics on cognitive function have been investigated and 
found to consist of impairment in verbal learning (Rosen, 
1979). Memory (Rosen, 1979; Bixler, 1979), and psycho-
motor performance (Hindemarch, 1979). Abuse of and 
withdrawal from hypnotics have also been found to induce, 
psychopathological disturbances, ranging from nervous 
states of exhaustion due to insomnia (Nicholson, 1980), 
paranoid psychoses and hallucinatory symptoms (Davison, 
1978) to acute delirium and dementia (Bergman; Borg & 
Holm, 1980). 
The use of clomethaziole has been reported to lead 
to dependence in patients, and abrupt withdrawal caused 
anxiety, excitement, disorientation and visual hallucina-
tions in patients (Hession, et al., 1979). According to a 
case report (Hession, et al., 1979), ethchlorvynol 
withdrawal included prolonged organic delirium with 
auditory, visual and tactile hallucinations. 
Withdrawal of methyprylon and glutethimide was 
found to induce psychopathological sysmptoms such as 
(grimacing, hallucinations, reduced cognitive performance 
and delirium (Hippius, 1978; Hall, et al., 1980). An over 
dose of methaqualone containing Nandrax led to a Schizo-
phrenia-like psychosis with visual and auditory hallu-
cinations, ideas of reference and shifting delusional 
ideas. 
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Triazolam/ a short-acting benzodiazepine mainly 
used as hypnotic agent/, was found to be effective for 
induction of sleep according to subjective assessments 
(Griffiths/ et al./ 1979). However/ recently severe and 
unwanted paradoxical reaction have been reported such as 
malaise/ depersonalization/ acute anxiety and alterations 
of mood and perception (Vander Kroef/ 1979). 
SEDATIVES : 
Withdrawal after chronic use of low-dose barbitura1:es 
(0.2g/day pentobarbitural) led to mild but persistent 
hallucinations. The use of barbiturates limited to the 
treatment of epilepsy and to anaesthesia/ side effects 
occur less frequently than before. AmOng the most common 
symptoms in bromide - containing substances and mania 
(Krauthamer/ & Klerman/. 1978) and neuropsychiatric distur-
bance/ i.e. impairment in vigilance, disorientation, 
delirium and hallucinations (Hall/ et al./ 1980). The 
bromocriptine has been associated with the onset of mania 
(Vlissides/ 1978)/ psychoses (Berglund/ 1977)/ and neuro-
logical disturbances (Shield/ et al./ 1977). The clinical 
picture of Bromide-induced symptoms is complex, with 
symptom shifts during presentation. 
Benzodiazepines are the most widely used sedatives. 
The prescription as well as consumption of drugs have 
dramatically increased during past decades and concern has 
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been expressed about their dependence potential (Tallman, 
et al., 1980), withdrawal symptoms and residual treatment 
effect. While the addition potential appears to be low 
(Jerram, 1981), neuropsychological impairment has been 
described in cases of abuse (Ayd, 1979). Psychological 
complications have been described in the use of hyposeda-
tives in dental practice (Lambert, 1980), withdrawal from 
chronic use of benzodiazepines may lead to a number of 
adverse effects including delirium, confusional states, 
transient psychoses and states of agitation (Jepsen,1979). 
Diazepam was found to produce dose-dependent 
changes in mood (increases in fatigue and confusion and 
decreases in vigor and arousal) in normal volunteers (File 
& Alyson, 1979). Cognitive and psychomotor impairment 
after diazepam intake has been widely highlighted in the 
literature. The effects include amnesia- like state and 
deterioration in reflex-speed, attention, learning, 
memory, perception and psychomotor coordination (Brown, 
1978; Hendler, 1980). More severe cases of psychopatho-
logical states, including depression have been described 
also after withdrawal of diazepam, again suggesting that 
their might be a diazepam addiction potential (Preskorn, & 
Denner, 1977; Hall et al., 1980). 
Psychiatric symptoms after lorazepeua have been seen 
in 569 anxious and 65 depressed patients; disorientation 
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and depression were detected in 0.7% Of the cases (Porter, 
& Lancee, 1978). Lorazepara may also lead to impaired 
performance and amnestic effect (File & Alyson, 1979), and 
withdrawal from the drug produced panic attacks with grand 
mal seizures (Howe, 1980; De la Fuente# et al., 1980). 
Clobazepam has been found to produce relatively few 
psychotropic effects, with the exception of drowsiness and 
decreased psychomofcox activity, the latter being less 
pronounced with clobazepam than with diazepam (Brogden, et 
al., 1980; Doulon,& Singer, 1979). 
PSYCHOSTIMDIANTS ; 
The pharmacologic activity of drugs such as 
amphetamine and dextroamphetamine are the principal 
psychostimulants. These medications are quite beneficial 
for treating the depressed. These agents cause an out 
pouring catecholamine from the presynaptic terminal into 
the synaptic cleft. A number of clinicians have noted the 
therapeutic efficacy of methylphenidate for reversing the 
apathetic behaviour of certain depressed elders (crook, 
1979). Data on prescribing from the National Disease and 
Therapeutic Index (Crook, 1979) suggests that more than 
20% of the out-patients with prescriptions for methyl-
phenidate are persons 65 years old and older. Most of 
these prescriptions are the symptoms of "Senility". 
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lethargy, sleep, desire for food and sometimes severe 
depression, which leads to an urge to resume the drug. 
Amphetamines has had multifarious uses, but its potential 
for abuse is such that it should only be used where 
essential, and this is rare. Amphetamines delays on-set 
of R.E.M. sleep, against fatigue seldom justified. 
Alternatives are preferable for appetite separation. Use 
of aiq>hetamines in sports is abuse. Chronic over dose can 
cause a psychotic state mimicking schizophrenia. Dexam-
phetamines, methan^hetamines, diethylpropion, methylphe-
midate« and Pemoline are similar to amphetamine. 
Khat : The leaves of the khat sl^ rub (catha edulis) 
contain an alkaloid structurally similar to ampheliamines. 
They are chewed fresh. Khat chewers became euphoric, 
excited, hyperactive and even mamic. As with some other 
drug dependencies subjects may give priority to their drug 
needs above personally, family and other social and 
economic responsibilities. 
Xanthines the three Xanthines» caffeine, theophylline 
and theobromine, occurs in plants they are quantitatively 
similar but differ markedly in potency. Tea contains 
caffeine and theophylline. Coffee contains caffeine and 
cocoa and chocolate contain caffeine and theobromine. The 
cola nut (cola drinks) contain caffeine. Caffeine theophy-
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nine have complex and incompletely elucidated on intra-
cellular calcium, on adenosine receptors and on nonadre-
nergic functions. Their capacity to inhibit the enzyme 
that breaks down cyclic MAP, occurs significantly only at 
concentrations higher than those reached in therapeutic 
use. When theophylline is used alongside Salbutamol in 
asthma their actions add upto increased benefit to the 
bronchi, but increased risk to the heart. 
Overdose can cause anxiety, tension and tremors 
will certainly reduce performance. The regular, frequent 
use of caffeine containing drinks is part of normal social 
life and mild over dose is common. Habitual tea and 
coffee drinkers are seldom willing to recognise that they 
have a psychological drug dependence. 
Caffeine is more potent than theophylline, but both 
drugs stimulate mental activity where it is below normal; 
they do not raise it above normal; thought is more rapid 
and fatigue is removed or its onset delayed. The effects 
on mental and physical performance vary according to the 
mental state and personality of the subject. Reaction-
time is decreased. Performance that is inferior because 
ofexcessive anxiety may become worse. 
Caffeine can (like amphetamine) also improve 
physical performance both in tasks requiring more physical 
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effort than skill (athletics) and in tasks requiring more 
skill than physical efforts (monitoring instruments and 
taking corrective action in an aircraft flight simulator). 
It is uncertain whether the improvement consists only of 
restoring to normal performance that is impaired by 
fatigue or boredom/ or whether caffeine (and amphetamine) 
can also enable subjects to improve their normal maximum 
performance. The drugs may produce their effects by 
altering both physical capacity and mental attitude. 
There is insufficient information on the effects on 
learning to be able to give any usual advice to students 
preparing for examination other than that intellectual 
performance may be assisted when it has been reduced by 
fatique or boredom. 
Effects on mood vary greatly amongst individuals 
and according to the environment and the task in hand. In 
general, caffeine (and amphetamines) induce feeling of 
alertness and well-being, euphoria or exhilaration. Onset 
of boredom, fatigue, inattentiveness and sleepiness is 
postponed. 
Other effects include Respiratory Stimulation, 
Sleep, Skeletal muscle. Cardiovascular System, smooth 
muscle and kidney failure. Acute over dose e.g. aminophylline 
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can cause convulsion/ hypotension cardiac dysrhythmia and 
sudden death. 
Ginseng is the root of two plants of the scune 
family (oriental/ Panax Ginseng; Siberian, Eleutherocous 
Senticosis). It contains a range of biologically active 
substances. It has been used as a tonic or stimulant for 
thousands of years. In man, ginseng has been claimed to 
benefit performance of athletes and astronauts, and to 
reduce absentism due to respiratory illness in mining and 
steel workers and truck drivers. Oriental soldiers at war 
have used ginseng. A range of adverse effects is reported 
including oedema, hypertension, rashes, diarrhoea, sleep-
lessness and oestrogen like effects. 
PSYCHODYSLEPTICS OR HALLUCINOGENS : 
Psychodysleptics or Hallucinogens produce mental 
changes that resemble those of some psychotic states. 
They are used by people seeking a new experience or 
escape. These drugs are also used by psychiatrists for 
supervising therapeutic sessions to encourage the release 
and releiving of unconscious material. The patient may 
gain insight and an improved ability to cope with his 
environment. Experiences with these drugs vary greatly 
with the subject's expectation, existing frame of mind and 
personality and environment. Subjects can be prepared so 
that they are more likely to have a good 'trip' than a bad 
'trip'. 
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Lysergic acid diethylamide (LSD) provides the 
nucleus of the ergoalkaloids. Tachyphylaxis (acute 
tolerance) occurs to LSD. Psychological dependence may 
occur, physical dependence does not. LSD has been used in 
the dying; it induced analgesia and indifferences. Its 
effect on the brain may partly be due to antagonism of 
Serotonin at auto receptors. Serious adverse effects 
include: Psychotic reactions with suicide; teratogenic and 
mutagenic effects are speculative and the risk is small at 
worsed. 
Mescaline is an alkaloid from a Mexican Cactus 
(Peyotal), the top of which is cut off and dried and used 
as 'Peyote buttons' in religious ceremonies. Mescaline 
does not induce serious dependence. 
Tenamf etamine ( N. D. A.: methy lenedioxy-methampheta-
mine) is structurally related to mescaline as well as to 
amphetamine; it is popularly known as 'ecstasy': Allied 
substance include STP (DOM) and DOB. 
Phencyclidine (Angeldust) was made in a search for 
a better intravenous anaesthetic. It is related to 
Pethidine It was found to induce analgesia without 
unconsciousness, but with amnesia, in man. Psychiatrist 
used this drug in the experimental therapy. Ketamine 
originates from this work. 
The Psilocybil is derived from v^rietd 
fungus; Psilocybe (Magic Mashrooms) that grow xn iiiaiii 
countries. It is related to LSD. 
PSYCHOLOGICAL DISORDERS IN SENESCENCE : 
Physical explanation of any psychological disorders among 
senescents can be more problamatic. because the psycho-
pathology found in the aged has not been directly linked to 
the physiological processess of aging. Maladaptive 
personality traits^ ill health, genetic predisposition, life 
stressors and inadequate coping skills into old age plays a 
role in the development of mental disorders. With these 
consideration in mind, we will first look at the prevalence 
of mental disorders in senescence and paying specific 
attention to depression, anxiety, insomnia and hypertension 
in the elderly. 
Depression; 
Depression is the most common of all mental disorders 
and it is particularly prevalent in senescense. Depression 
is a common psychiatric diagnosis in the elderly. Its 
prevalence in the community has been reported to vary from 
67/1000 to 241/1000. Depression is thrice more common than 
mania above the age of 60. Affective Disorders (Mania and 
Depression) and psycho organic syndromes constitutes 2/3rd 
and l/3rd respectively of the total psychiatric morbidity 
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in the elderly. The depression is often invisible in the 
community (Venkoba Rao,& Devi, 1990). Simple depressive 
episodes might be regarded as inevitable accompaniment of 
multiple losses- loss of friends and family members; loss 
of role, status and therefore self esteem; and loss of 
health and sensory function, with accompanying damaged self 
image (Zetzel, 1978). Simple depression is referred to as 
"reactive" because it is triggard by external events. 
Depression associated with intrapsychic conflict has no 
apparent precipitating cause. 
Unipolar depressions are much more common in the 
elderly than are bipolar depressions (Post, 1978; Regier, et 
al., 1988). The onset of bipolar disorder after the age of 
65 is believed to be rare (Jamison, 1979; Regier^ et al., 
1988) found almost no person aged 65 or older who met 
diagnostic criteria for mania. 
Sometimes the term secondary depression is applied where 
the depression is believed to accompany or result from any 
of the many physical illnesses to which older adults are 
subject. It is prevalence of these kinds of depression 
that give rise to estimates that depression is generally 
more common among older than among younger adults. (Cohen, 
1990; Kermis, 1986). 
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Another classification distinguishes between 
"neurotic depression" and "Psychotic depression" on the 
basis of the severity of the psychopathology. Psychotic 
depression is accompanied by serious impairment of reality 
testing/ along with guilt and massive self approach, 
profoundly diminishing the person's capacity to meet the 
ordinary demands of life. Common symptoms of depression or 
insomnia with difficulty falling asleep as well as early 
morning awakening; poor appetite or excessive eating; 
constipation; crying spells, feeling of hopelessness, 
helplessness and worthlessness; and suicidal thoughts. 
Depression in the aged can be masked by somatic complaints 
and can be induced by excessive doses of tranquilizing 
medication such as diazepam (Valium) (Comfort, 1980; 
Reidenberg, 1980). 
Indian studies have shown depression to be a common 
diagnosis among elderly psychiatric patients (Ramachandran 
& Sarada Menon, 1980; Venkoba Roa & Madhavan, 1982). 
ANXIETY DISORDER : 
The moderate level of anxiety is normal, appropriate 
and even useful response to life events and situations 
provided. It stimulates achievements that may mitigate or 
remove the cause. But inappropriate or excessive or 
chronic anxiety is disably specially where the cause cannot 
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be removed. Anxiety may also occur with apparent exoge-
neous cause,and subjects of this free floating anxiety need 
attention and help. 
Anxiety disorders are not purported to be the sole 
diagnosis made on first contact with the patient (Turnbull, 
& Turnbull, 1985). The diagnosis is often missed or is 
reached when every thing else has been ruled out. Yet they 
are exceedingly common, occuring more frequently in women 
than in men across all age groups, but increase in 
frequency with advancing age (Carey, et al., 1980; Klein^ et 
al., 1981). Meyers'^ et al. (1984) indicated that for the 
elderly, the prevalence of panic disorders, obsessive 
compulsive disorder and phobias combined range between 5.7% 
and 33%. 
HYPERTENSION : 
Blood pressure refers the pressure at which blood is 
pumped from the heart into the main arteries to be distri-
buted around the body. The blood pressure recorded consist 
of two readings. The upper reading is the pressure at the 
point when the contractions (systole) of the heart forces 
the pulse wave of blood through the artery from which the 
pressure is recorded. This is known as the systolic blood 
pressure. The second reading is the pressure recorded 
between the pulse waves when the heart is relaxed, and 
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filled with blood (diastole) ready for the next pumping 
actions- this is called diastolic blood pressure. 
Blood pressure varies a great deal, even for the 
same individual, with such events as anxiety, exercise, 
standing, sitting and lyingdown, as well as a full bladder, 
pain, cold, and drugs unconnected with, the control of 
blood pressure. This variation is even greater among older 
people. 
Essential Hypertension is one of the most serious 
psychophysiological disorder and it is commonly called as 
high blood pressure. This diseases disposes people to 
atherosclerosis (clogging of the arteries), heart attacks, 
and strokes and it can also cause death through kidney 
failure. Essential hypertension is currently viewed as a 
hetrogeneous condition brought on by many possible 
disturbances in the various systems of the body that are 
responsible for regulation blood pressure. Blood pressure 
may be deviated by increased cardiac output, the amount of 
blood leaving the left ventricle of the heart per minute; 
by increased resistance to the passage of blood through the 
arteries and by an increase in the body's volume of fluids. 
The combination of the physiological mechanisms that 
contribute to regulation is extremely complex. The sympa-
thetic nervous system, hormones, and salt and water 
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metabolism, as well as central nervous System, mechanism, 
are all involved (Weiner, 1977). It is well known that 
blood pressure rises with strong emotion, with physical 
demands, and with increasing age, but the exact mechanism 
of essential hypertension is still unknown. On an inter-
national level, hypertension has been linked to rapid 
sociocultural change. It is alleged that uncertainty over 
one social role in a changing society is the specific 
stress leading to hypertension. 
INSO!fllIA : 
Insomnia is a frequent complaint among the elderly. 
Chronic life long insomnia is often associated with a 
variety of disorders or emotional conflicts. The most 
common problems are awakening often at night, frequent 
early morning awakening, difficulty falling asleep, and day 
time fatigue (Miles & Dement, 1980). These complaints have 
been found to parallel the physiological changes that occur 
normally in the sleep patterns of older adults (Bootzin et 
al., 1983). Sleep is more often spontaneously interrupted 
as people grow older thus older people generally sleep less 
in relation to the total time they spend in bed. In 
addition, the elderly spend less absolute time in a phase 
known as Rapid Eye Movement (REM) sleep; and stage for 
sleep the deepest, is virtually absent. In general, 
elderly men appear to have more disturbances of their sleep 
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than do women/ a difference found to a lesser extent in 
young adults (Dement et al., 1981). 
Clift (1975) reported several psychological causes 
of insomnia including depression, anxiety, alcoholism, 
schizophrenia, and normal psychological reactions, such as 
anxiety about personal welfare (Financial employment 
worries) and anxiety about welfare of others (illness in a 
near relative, marriage of child). 
Association of sleep disorder centers proposed the 
different types of insomnia; 
(I) Transient and Situational Insomnia; 
Temporary insomnia may be associated with medical, 
surgical, or traumatic conditions; admissions to a hospital 
or sleeping in any new environment, with personal stress 
and anxiety, as in bereavement; and with disturbances of 
biological rhythms, such as "Jet Lag" or shift work. 
Other common conditions associated with insomnia include 
occupational changes, moving to a new location, severe 
illness in a close relative or friend, termination of a 
romantic relation, test anxiety and so forth. 
(II) Insomnia Associated with Mental Disorders: 
Psychological symptoms such as anxiety, depression, 
and concern about physical well-being are common in 
insomniac patients. Complaints about sleep disturbances 
40 
are common in psychiatric patients. It is not clear 
whether sleep disturbances causes the psychological 
distress or whether the psychological stress disrupts 
sleep or the subjective satisfaction of sleep. 
(Ill) Insomnia Associated with Use of Drugs and Alcohol; 
Dependence on, tolerance to, and withdrawal from 
hypnotic agents themselves may be major factors in the 
complaints of some insomniac patients. Some chronic 
insomniac patients received prolong treatment with high 
doses of hypnotics appear to sleep worse than similar 
patients without hypnotic treatment (Kales,et al., 1974). 
Some insomniacs appear to sleep better once they have 
handed their dependence upon hypnotics, or at least, they 
probably sleep low worse. Patients may experience a 
withdraval insomnia. IThen first discontinue sleeping pills 
because of psychological habituation, physical dependence 
on hypnotics agents, and possibly, other pharmacologic 
effects (KaleS; et al., 1974, 1978). Major withdrawal 
symptoms including convulsions may occur when multiple 
doses of hypnotics have been taken. 
Alcohol is a particular issue for insomniac 
patients. Alcohol is the most commonly used self-
medication for sleep. In general, occasional use of 
alcohol may induce sleep, but it also of ten disrupts arid 
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fragments sleep. Chronic alcoholics often have markedly 
disturbed sleep patterns, persisting as long as two years 
after "drying-out" (Adamson^ & Burdick, 1973). Alcohol, 
when taken in combination with any hypnotic agent, can be 
toxic or lethal. These untoward effects can occur in non 
alcoholics as well as alcoholics, and at relatively low 
doses of hypnotics in combination with relatively low 
amounts of alcohol. Stimulants and caffeine occasionally 
cause insomnia. Drugs such as reserpine or steroids may 
produce psychological depression, which inturn is 
associated with insomnia. 
(IV) Sleep-induced Ventilatory Impairment : 
Apnea, is a state when breath stops for about 10 
seconds to over 60 seconds. Hundred of apnic episodes may 
occur each night without the patient's awareness. In many 
cases, an apnea affected person may suddenly dose off on 
steering heels and meet with an accident. Insomnia may 
result from respiratory disturbances. Patients with 
chronic obstructive pulmonary disease are prone to sleep 
apnea or hypoventilation (Wynne, et al., 1978). The 
insomnia associated with sleeping at high altitudes may be 
related to sleep apnea (Kryger^ et al., 1978; Miller, & 
Howat., 1977). Hypnotics are respiratory depressants. 
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(V) Insomnia Associated with Nocturnal Myoclonus and 
"Restless legs" Syndrome : 
Nocturnal myoclonus is characterised bilateral, 
fleeting muscular jerks, usually of the anterior tibian 
muscles, occuring during sleep at interval of about 20 to 
40 seconds (Guilleminault^ et al., 1976). Nocturnal 
myoclonus may occur in variety of sleep disorders, 
including narcolepsy, sleep apnea, depression, drug 
dependence and in normal subjects. Restless legs 
syndrome (Farankel, et al., 1974; Botez,& Lambert, 1977), 
often associated with nocturnal myoclonus, is character-
ised by an uncomfortable feeling in the thigh (Similar to 
akesthesia) when the patient is resting. 
(VI) Insomnia Associated with Disruption of 
24 hours sleep - wake cycle ; 
Disturbances of basic biological rhythms may also 
produce insomnia. Tn the phase-lags syndrome, the patient 
is unable to fall asleep at the desired time (say 11 pm), 
but can sleep readily and well beginning at a latter time 
(say 3 am). The major problem is that the patient sleeps 
through alarm clocks and is unable to get up or maintain 
normal vigilence during the morning hours at work or school. 
This syndrome is often associated with an altered circa-
dianbody temperature curve, suggesting that the patient is 
'out of phase "with the normal environment. The "jet-lag 
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syndrome" is a transient disturbance that is the result of 
rapid time zone change. 
(VII) Insomnia Associated with Medical Conditions : 
Insomnia is rarely the soul presenting chief 
complaint of a medical condition but it can be in orthopnea, 
paroxysmal, nocturnal dyspnea, and dementia. Hepatic, 
pulmonary, or renal insufficiency may predispose certain 
patients to toxic reactions when taking hypnotics (Jick, 
1977). 
(VIII) Other conditions Associated with Insomnia : 
Insomniac patients have reported other disorders 
associated with sleep: hyperactive gang reflex, REM sleep 
interruption insomnia (Greenberg, 1967), asystole during 
REM sleep in otherwise healthy adults (presenting as chest 
pain during sleep) (Guilleminault et al, 1978) or atypical 
and abnomral ecg wave forms (Hauri, 1976). 
(IX) Persistant Insomnia of unknown Origin : 
There are a group of patients who are here called 
"Primary Insomniacs". Although these patients are often 
psychologically distress, they do not meet the diagnostic 
criteria of a primary psychiatric illness. These patients 
often insist that insomnia is their primary problem and 
their subjective psychological distress is secondary to 
it. Some investigators believe that psychosocial problems 
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are still the main factor in the patient's insomnia 
despite the patient's claim to contrary (Kales, et al., 
1976). 
SIGNIFICANCE OF THE PRBSEMT STDDY : 
The present study falls in the field of Addictive 
Behaviour. The misuse of prescription and over the 
counter medicines is a much greater problem in the aged 
population than drug or alcohol abuse (LaRue, et al., 
1985). The present investigator views thf't the elderly of 
any group: the young-old, the old-old, and the oldest old 
need to understand why they are taking a drug, what it is 
called and how they feel after taking a drug. No syste-
matic study of the use of psychotropic drugs and their 
psycho-physical consequences in senescents have been done. 
RESEARCH OBJECTIVES : 
The aims of the present study are: (a) to study the 
prevalonce of use of psychotropic drugs with a potential 
to alleviate psychological disorders among male and female 
senescents, (b) to make comparison between the male and 
female senescents percentages scores on reasons for taking 
drugs, and (c) to examine differences between the mean 
scores of male and female senescents on various charac-
istics representing to psycho-physicalconsequences of 
drugs. 
CHAPTER - II 
M E T H O D O L O G Y 
The main aim of the present study is to assess the 
reasons for taking drugs and psycho-physical consequences 
of the use of psychotropic substances 2unong the male and 
female senescents. The present chapter included sample/ 
toolsf procedure and data analysis. 
SAMPLE 
Initial Sample; 
The sample was restricted to twenty five male and 
twenty five female senescents. The sample was purposively 
selected for identifying reasons of drug taking and the 
psycho-physical consequences associated with psychotropic 
drugs. The investigator retained only those traits as 
items in each check list (i.e., 'reasons' and 'psycho-
physical consequences) where there was agreement over 
fifty percent among the senescents' reporting. 
Final Sample; 
Seventy five male and seventy five female 
senescents (age range 65-95 years) of Aligarh and Rampur 
Districts of U.P. constituted the sample. Majority of the 
senescents were taking psychotropic drugs (AnxioLyticSf 
Anti-depressants, Minor Tranquilizers) for more than three 
years. According to self reported socio-demographic data 
all the senescents were belonging to Urban background/ 
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married» literate» illetrate and joint and nuclear family. 
Majority of the subjects were Muslims. 
TOOLS; 
Reasons for taking drugs was assessed through a 
check list developed by the investigator. This check list 
consisted of fifteen reasons viz: Anxiety, Boredom, Can't 
relax# Chronic physical pain. Depression/ Fatigability# 
Headache, Hopelessness# Insomnia/ Loneliness, Loss of 
control/ Nervousness/ Palpitation/ Somatic pre-occupation/ 
and Tension. 
Psycho-physical consequences associated with drug 
taking behaviour was assessed through a twenty item check 
list namely- Anxious/ Calm, Constipation, Depressed/ 
Dizziness/ Drowsiness/ Excited, Frustrated/ Healthy/ 
Hostile, Loss of Body Weight, Loss of memory. Nervous, 
Relaxed, Restless, Sadness/ Secure/ Sickly/ Tense and 
Weakness- prepared by the investigator herself. Each 
characteristic or items was answered on a 5-point scale 
ranging from a very often to never. Each item get a score 
of 4 for "very often"/ 3 for "quite often"/ 2 for 
"sometimes"/ 1 for "rarely"/ and 0 for "never". 
PROCEDURE; 
Prior to data collection/ the investigator engaged 
herself in informal conversations with the senescents. 
During this interaction she asked some questions to the 
respondents. What problems you have at present? Are you 
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taking drugs? How long you are using these drugs? How 
important is it for you to take these drugs? What is 
likely to happen if you don't take them? When you had 
taken such type of drugs ( i.e. psychotropic)? Subjects 
who were not using any psychotropic drugs or reluctant to 
report their problems were not included in the final 
sample. 
Data were collected through face to face interview 
method or by administering the tools on the subjects. 
When the subjects expressed their willingness to 
participate as subjects, they were administered socio-
demographic data sheet, check list, meant for measuring 
the "reasons for taking drugs" and "psycho-physical 
consequences of drugs". The investigator also noted down 
the names of the prescribed drugs from the treatment card 
or the subjects who reported verbally to her. Subjects 
were also asked to write down or report any other reason 
for taking drugs which is not listed Vis-a-Vis the 
characteristic which is not listed in the check list 
measuring the psycho-physical consequences of drugs. 
DATA ANALYSIS : 
Data were analysed by means of simple percentages. 
Critical Ratio(C.R.) of percentages and t-test. Simple 
percentages were computed for determining the prevalence 
rate of psychotropic drugs among male and female senes-
cents. Critical Ratio was used for determining the 
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difference between male and female senescents' percentages 
obtained on the traits or items. t-test was applied for 
determining the differences between the mean scores of 
male and female senescents on the traits representing to 
psycho-physical consequences of drugs. 
CHAPTER - III 
RESULTS^ DISCUSSION AND CONCLOSIONS 
The data analysed by means of simple percentages. 
Critical Ratio, and t-test are presented in Tables 1-3: 
Table 1; Psychotropic Drugs prescribed for Male and 
Female senescents during the period 1993-1995 by 
Doctors. 
Prescribed Drugs N Male N Female 
Nindral 
Surmontil 
Tancodep 
Tetradep 
Tradozep 
Anxiolytic :s/Sedatives 
Minor Tranquilizers 
6 
8 
7 
7 
6 
Percentages 
8.00 
10.66 
9.33 
9.33 
8.00 
7 
8 
9 
6 
10 
Percentages 
9.33 
10.66 
12.00 
8.00 
13.33 
Alprax 6 8.00 8 10.66 
Alzolam 6 8.00 
Ativan 13 17.33 15 20.00 
Betaspan 6 8.00 
Calmpose 10 13.33 22 29.33 
Diazepam 11 14.66 6 8.00 
Equilibrium - - 10 13.33 
Nitrosun 6 8.00 8 10.66 
Stress 10 13.33 5 6.66 
Trinicalm 7 9.33 6 8.00 
Valium 5 8.00 9 12.00 
Zolax 8 10.66 
Zolam 9 12.00 5 6.66 
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Table 2 : Indicating the comparison between the per-
centages scores of male (N=75) and female 
(N=75) senescents on various traits represent-
ing the 'reasons for taking drugs'. 
Traits (Sal£S.(Pl) Females (Py) C.R. P 
Percentages Percentages 
Anxiety 50.66 
Boredom 2 0.00 
Can't relax 30.66 
Chronic Physical 66.66 
pain 
Depression 44.00 
Fatigability 48.00 
Headache 40.00 
Hopelessness 2 0.00 
Insomnia 38.66 
Loneliness 40.00 
Loss of control 14.66 
Nervousness 13.33 
Palpitation 17.33 
Somatic 2 6.66 
preoccupation 
Tension 33.33 
4 1 . 3 3 
1 3 . 3 3 
2 4 . 0 0 
74 .66 
42 .66 
56 .00 
82 .66 
14 .66 
6 0 . 0 0 
2 0 . 0 0 
1 3 . 3 3 
2 0 . 0 0 
2 4 . 0 0 
50 .66 
50 .66 
1 .16 
1 . 1 1 
0 .92 
1 . 0 8 
0 . 1 6 
0 . 9 9 
5 . 4 3 
0 . 8 7 
2 . 6 4 
2 . 7 1 
0 . 2 3 
1 . 1 1 
1 .02 
3 . 0 5 
2 . 1 7 
> .05 
. > .05 
> .05 
> .05 
> .05 
> .05 
< .01 
> .05 
< .05 
< .01 
> .05 
> .01 
> .05 
< . 0 1 
< .05 
51 
Table 3 ; Indicating comparison between the mean scores 
of male and female senescents on various traits 
associated with the psycho-physical conse-
quences of drugs. 
Traits 
Anxious 
Calm 
Constipation 
Depressed 
Dizziness 
Drowsiness 
Excited 
Frustrated 
Healthy 
Hostile 
Loss of Body Weight 
Loss of Memory 
Nervous 
Relaxed 
Restless 
Sadness 
Secure 
Sickly 
Tense 
Weakness 
Male 
Senescents 
Mean 
1.80 
2.86 
1.40 
1.36 
2.00 
1.53 
1.72 
2.05 
2.60 
1.77 
1.38 
1.62 
1.56 
2.80 
1.72 
1.83 
2.13 
2.19 
1.84 
3.13 
SD 
1.10 
0.86 
0.58 
0.55 
0.86 
0.61 
0.94 
1.05 
1.01 
0.53 
0.48 
0.98 
0.99 
1.02 
0.85 
1.08 
1.08 
0.64 
0.98 
0.86 
Fonale 
Senescents 
Mean SD 
1.86 
3.53 
1.62 
1.57 
1.77 
2.00 
1.93 
1.93 
3.07 
1.75 
1.54 
1.71 
1.47 
3.15 
1.86 
1.46 
3.00 
1.63 
1.71 
3.52 
0.80 
0.67 
0.98 
0.67 
0.78 
1.03 
1.14 
0.86 
0.84 
0.74 
0.78 
1.02 
0.65 
0.87 
0.87 
0.71 
1.00 
0.86 
0.25 
0.60 
t-values 
0.37 
5.28 * 
1.66 
1.34 
1.70 
3.37* 
1.22 
0.07 
3.07* 
0.18 
1.50 
0.54 
0.03 
2.24 
0.99 
1.75 
5.08* 
4.49* 
1.10 
0.12 
** 
p< .01 level of significance 
p< .05 level of significance 
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Table 1 showing the percentages of male and female 
senescents who reported that they had taken different 
types of psychotropic drugs in the previous three years. 
Results showed that the percentages of prescribed anti-
depressant drugs were more for females than for males. 
And the percentages of male and female senescents 
receiving anxiolytics, sedatives and minor tranquilizers 
were of almost equal. Every male and female senescent was 
using at least one psychotropic drug per day. 
Both male and female senescents have reported that 
in addition to the psychotropic drugs they were also 
using different types of medicines prescribed by doctors. 
The medicines that were prescribed to them were: health 
salts, indigestion remedies, laxatives, throat or cough 
medicines, cold or congestion relievers, aspirin or other 
pain killers, skin ointments, antiseptics , eye drops, 
lotions, ointments, things to sniff, diarrhoea medicines, 
tonics, rejuventors, slimming aids, vitamin tablets, 
medicinal foods etc. 
Female senescents scored significantly higher than 
the male senescents on headache (t=5.43, p< .01), insomnia 
(t=2.64, p<.05), somatic preoccupation (t=3.05, p<.01), 
and tension (t=2.17, p<.05) traits. On loneliness trait 
male senescents scored significantly higher than the 
female senescents (t=2.71, p<.01). Male and female senes-
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cents reported boredom, hopelessness, nervousness, palpi-
tation, and loss of control as the minor reasons (i.e. 
below 25%) for taking psychotropic drugs. 
Female as compared to male senescents scored 
significantly higher on relaxed (t=2.24, p<.05), calm 
(t=5.28, p<.01), healthy (t=3.07, p<.01), secure (t=5.08, 
p<.01) and drowsiness (t=3.37, p<.01) traits associated 
with psycho-physical consequences of drug taking behav-
iour. Sickly was the only trait where the males scored 
significantly higher than the females (t=4.49, p<.01). 
Significant differences were not found between male and 
female senescents on tense, weakness, depressed, nervous, 
frustrated, anxious, loss of memory, hostile, sadness, 
excited, constipation, restless, loss of body weight and 
dizziness traits (cf. Table 2) representing to psycho-
physical consequences of drug taking behaviour. 
Data presented in Table 2 suggests that the male 
and female senescents were taking psychotropic drugs 
because of several physical and psychological problems 
(reasons). As it is evident from the results presented dn 
Table 3, more female than male senescents reported 
positive as well as negative reactions. Patients who 
developed adverse reactions were found to have been given 
more drugs than those who did not. This finding implies 
that females possess more symptoms of illness than males 
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and makes greater use of health services. In general, the 
percentage with which unwanted psycho-physical consequen-
ces of drugs occur depends on how and by whom they are 
identified; whether they are taking prescribed or non-
prescribed medicines. Prescribed drugs can lead to 
multiple physical and psychological consequences. It is 
mainly due to non-comprehension and non-compliance. That 
is, dosage errors may be associated with the number of 
drugs scheduled, the frequency of daily doses, drugs given 
by an individual, and taken dosages when they felt they 
were necessary. What is clear is that for a wide variety 
of reasons the male and female senescents are particularly 
exposed to and vulnerable to unwanted psycho-physical 
effects. 
Some of the significant observations noted down by 
the investigator during the period of conducting survey 
are as follows: 
1. Drug misuse was a major problem among twenty 
five females (33.33%) and fifteen males (20.00%). 
They reported that they had not consulted their 
doctor at all in the previous six months. 
2. More than fifty percent male and female 
senescents rated their health as "poor". 
S5 
3. Some of the elderly people were reluctant to 
admit or to report their problems. 
4. Peoples were unaware about the type of drugs 
they were taking, what they were and how they 
were likely to help. Some elderly argued that 
the drugs should be prescribed with the consent 
of the patient. 
5. The proportions of male and female senescents 
who reported that they had taken different types 
of medicines in the previous three months. 
CONCLUSIONS : 
The findings of the present investigation provides 
an information about the reasons of taking psychotropic 
drugs and psycho-physical problems faced by male and 
female senescents. Drug therapy has brought many gains in 
alleviating disorders of senescents. Clearly, many drugs 
are capable of improving quality of life experienced by 
senescents/ many of whom face debilitating physical and 
psychological illnesses. Unfortunately, even for those 
drugs that work, there are invariably costs, side effects 
or adverse reactions. This is particularly true with 
older senescents. The findings of the present study 
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demonstrated the undesirable psycho-physical consequences 
(effects) are particularly common with psychotropic drugs 
(minor and major tranquilizers, anxiolytics, and anti-
depressents). 
More research is required regarding the relation-
ship between type of drugs and physical, and psychological 
effects among younger and older people. Further research 
is needed to test as to whether a smaller dose of a drug 
will produce the same effect as the higher dose for a 
elderly person. Doctors should discuss with patients 
about the drugs th'ey prescribe or possible alternatives to 
drugs. This suggestion arises that some doctors interact 
with their patients in such a way as to encourge long term 
use. Speaking very generally, prescribing psychotropic 
drugs should be a short-term affair. It would be 
important to consider the substantial potential both for 
adverse inter drug reactions and for general adverse drug 
reactions associated with excessive use. There is wide 
scope for research in this field, considering the role of 
some demographic factors (i.e. age, sex, socioeconomic 
status, type of family, are of residence, etc.) upon the 
psycho-physical effects. To establish whether psycho-
logical disorders can be a source of adverse effect of a 
psychotropic drug, studies with a different methodology 
and on larger samples of population are required. 
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